Baillie Gifford - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 109 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$837,977
-60.2%
4,869,126
+0.3%
0.00%
-50.0%
Q3 2022$2,105,000
-49.6%
4,853,773
-1.1%
0.00%
-50.0%
Q2 2022$4,174,000
-84.6%
4,906,078
-0.0%
0.00%
-78.9%
Q1 2022$27,039,000
-43.4%
4,907,471
-0.5%
0.02%
-26.9%
Q4 2021$47,730,000
-43.1%
4,930,859
+5.0%
0.03%
-40.9%
Q3 2021$83,927,000
-26.8%
4,693,832
-0.0%
0.04%
-21.4%
Q2 2021$114,605,000
-7.9%
4,695,022
+0.0%
0.06%
-20.0%
Q1 2021$124,388,000
+247.9%
4,693,871
-0.3%
0.07%
+250.0%
Q4 2020$35,749,000
+66.9%
4,710,061
+10.2%
0.02%
+33.3%
Q3 2020$21,413,000
-15.8%
4,273,861
+0.4%
0.02%
-21.1%
Q2 2020$25,444,000
+34.3%
4,254,732
-0.1%
0.02%
-9.5%
Q1 2020$18,943,000
-53.1%
4,256,900
+0.1%
0.02%
-46.2%
Q4 2019$40,390,000
+21.3%
4,251,470
+0.3%
0.04%
+2.6%
Q3 2019$33,290,000
-50.0%
4,240,767
+0.1%
0.04%
-46.5%
Q2 2019$66,612,000
-11.0%
4,234,682
+2.5%
0.07%
-13.4%
Q1 2019$74,804,000
+14.7%
4,132,851
+1.9%
0.08%
-3.5%
Q4 2018$65,223,000
-30.5%
4,056,196
+3.7%
0.08%
-15.8%
Q3 2018$93,831,0003,909,6120.10%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders